10 mg natura-alpha capsule    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis1

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01216280
(ClinicalTrials.gov)
July 20102/9/2010Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative ColitisEfficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative ColitisUlcerative ColitisDrug: placebo capsule;Drug: 10 mg Natura-alpha capsule and 10 mg placebo capsule;Drug: 2 x 10 mg Natura-alpha capsulesNatrogen Therapeutics International, IncNULLActive, not recruiting18 Years70 YearsBoth75Phase 2United States